Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Leuk Lymphoma. 2018 Jul 22;60(2):402–408. doi: 10.1080/10428194.2018.1480768

Figure 1.

Figure 1.

Individual symptom severity, prevalence, and correlation with quality of life. Symptom severity was measured as 0 (absent) to 10 (worst imaginable) using the MPN Symptom Assessment Form. Prevalence was defined as a symptom score greater than or equal to 1. Pearson’s correlations shown are between each symptom and quality of life as measured by the Global Health Status/Quality of Life scale of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 3.